januar 28, 2023

Q-VD-OPh hydrate

Q-VD-OPh hydrate 

To Order Contact us: bjorn@lembcke.dk

Q-VD-OPh hydrate

GK2336-1MG 1 mg
EUR 316.8

Q-VD-OPh hydrate

GK2336-5MG 5 mg
EUR 1033.2

Q-VD-OPh

1170-1
EUR 280.8

Q-VD-OPh

1170-3
EUR 529.2

Q-VD-OPh

1170-5
EUR 874.8

Q-VD-OPh

1170-50 Ask for price

Q-VD-OPh

HY-12305 10mM/1mL
EUR 228

EZSolution? Q-VD-OPh

1173-1
EUR 248.4

Q-VD(OMe)-OPh

A8165-1 1 mg
EUR 212.4
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

Q-VD(OMe)-OPh

A8165-10 10 mg
EUR 756
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

Q-VD(OMe)-OPh

A8165-25 25 mg
EUR 1173.6
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

Q-VD(OMe)-OPh

A8165-5 5 mg
EUR 477.6
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

Q-VD(OMe)-OPh

A8165-5.1 10 mM (in 1mL DMSO)
EUR 853.2
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

Q-VD(OMe)-OPh

A8165-S Evaluation Sample
EUR 97.2
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor,  provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors.

(R)-Q-VD-OPh

HY-12305A 10mg
EUR 308.4

EZSolution? Q-VD-OPh, Negative Control

1174-1
EUR 248.4

Pan-caspase inhibitor, Q-VD(OMe)-OPh

2787-1
EUR 314.4

Pan-caspase inhibitor, Q-VD(OMe)-OPh

2787-5
EUR 966

Q-VE-Oph

GL5302-1MG 1 mg
EUR 302.4

EZSolution? Q-DEVD-OPh

1178-1
EUR 326.4

Caspase-3 Inhibitor Q-DEVD-OPh

1175-1
EUR 326.4

Caspase-3 Inhibitor Q-DEVD-OPh

1175-3
EUR 639.6

Caspase-3 Inhibitor Q-DEVD-OPh

1175-5
EUR 966

Caspase-8 Inhibitor, Q-IETD-OPh

1176-1
EUR 366

Caspase-8 Inhibitor, Q-IETD-OPh

1176-3
EUR 823.2

Caspase-8 Inhibitor, Q-IETD-OPh

1176-5
EUR 1188

Caspase-9 Inhibitor, Q-LEHD-OPh

1177-1
EUR 352.8

Caspase-9 Inhibitor, Q-LEHD-OPh

1177-3
EUR 810

Caspase-9 Inhibitor, Q-LEHD-OPh

1177-5
EUR 1161.6

VD/ Rat VD ELISA Kit

ELA-E0917r 96 Tests
EUR 1063.2

QVD-OPh Negative Control

1171-1
EUR 248.4

QVD-OPh Negative Control

1171-3
EUR 483.6

QVD-OPh Negative Control

1171-5
EUR 705.6

VD-PEG-NH2,2K

33-HE090005-2K
  • EUR 681.60
  • EUR 1909.20
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Sheep VD ELISA Kit

ESV0030 96Tests
EUR 625.2

Human VD ELISA Kit

EHV0030 96Tests
EUR 625.2

Human VD ELISA Kit

EHV0033 96Tests
EUR 625.2

Porcine VD ELISA Kit

EPV0030 96Tests
EUR 625.2

Porcine VD ELISA Kit

EPV0033 96Tests
EUR 625.2

Monkey VD ELISA Kit

EMKV0030 96Tests
EUR 625.2

Mouse VD ELISA Kit

EMV0030 96Tests
EUR 625.2

Mouse VD ELISA Kit

EMV0033 96Tests
EUR 625.2

Rabbit VD ELISA Kit

ERTV0030 96Tests
EUR 625.2

Rabbit VD ELISA Kit

ERTV0033 96Tests
EUR 625.2

Rat VD ELISA Kit

ERV0030 96Tests
EUR 625.2

Rat VD ELISA Kit

ERV0033 96Tests
EUR 625.2

Goat VD ELISA Kit

EGTV0030 96Tests
EUR 625.2

Goat VD ELISA Kit

EGTV0033 96Tests
EUR 625.2

Anserini VD ELISA Kit

EAV0030 96Tests
EUR 625.2

Anserini VD ELISA Kit

EAV0033 96Tests
EUR 625.2

Bovine VD ELISA Kit

EBV0030 96Tests
EUR 625.2

Bovine VD ELISA Kit

EBV0033 96Tests
EUR 625.2

Chicken VD ELISA Kit

ECKV0030 96Tests
EUR 625.2

Canine VD ELISA Kit

ECV0030 96Tests
EUR 625.2

Canine VD ELISA Kit

ECV0033 96Tests
EUR 625.2

Horse Vitamin D(VD)

QY-E120083 96T
EUR 573.6

Creatine hydrate

CB0326 100g
EUR 73.57

Doripenem hydrate

D004-25MG 25 mg
EUR 170.4

Doxycycline hydrate

D064-25G 25 g
EUR 176.4

Doxycycline hydrate

D064-5G 5 g
EUR 70.8

Cephalexin Hydrate

C024-10G 10 g
EUR 249.6

Cephalexin Hydrate

C024-25G 25 g
EUR 450

Cephalexin Hydrate

C024-5G 5 g
EUR 158.4

Tivozanib (hydrate)

C3415-10 10 mg
EUR 259.2
Description: Tivozanib, also known as AV-951 and KRN-951, is an orally active, ATP-competitive, small-molecule, quinoline-urea derivative. Tivozanib is a pan-VEGFR tyrosine kinase inhibitor.

Tivozanib (hydrate)

C3415-5 5 mg
EUR 208.8
Description: Tivozanib, also known as AV-951 and KRN-951, is an orally active, ATP-competitive, small-molecule, quinoline-urea derivative. Tivozanib is a pan-VEGFR tyrosine kinase inhibitor.

FR122047 (hydrate)

C5551-10 10 mg
EUR 247.2
Description: FR122047 is a selective inhibitor of cyclooxygenase (COX)-1 [1].Cyclooxygenase (COX)-1 is constitutively expressed in almost all tissues. COX-1 gene has been considered to be a ?housekeeping? gene.

FR122047 (hydrate)

C5551-5 5 mg
EUR 164.4
Description: FR122047 is a selective inhibitor of cyclooxygenase (COX)-1 [1].Cyclooxygenase (COX)-1 is constitutively expressed in almost all tissues. COX-1 gene has been considered to be a ?housekeeping? gene.

FR122047 (hydrate)

C5551-50 50 mg
EUR 877.2
Description: FR122047 is a selective inhibitor of cyclooxygenase (COX)-1 [1].Cyclooxygenase (COX)-1 is constitutively expressed in almost all tissues. COX-1 gene has been considered to be a ?housekeeping? gene.

Doripenem Hydrate

E1KS1374 10mg
EUR 625.2

Cefadroxil (hydrate)

C3991-1000 1 g
EUR 513.6
Description: Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential [1]. In vitro: The inhibitory activity of this compound was similar to that of cephalexin and cephradine when tested against 602 clinical isolates on Mueller-Hinton medium.

Cefadroxil (hydrate)

C3991-250 250 mg
EUR 195.6
Description: Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential [1]. In vitro: The inhibitory activity of this compound was similar to that of cephalexin and cephradine when tested against 602 clinical isolates on Mueller-Hinton medium.

Cefadroxil (hydrate)

C3991-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential [1]. In vitro: The inhibitory activity of this compound was similar to that of cephalexin and cephradine when tested against 602 clinical isolates on Mueller-Hinton medium.

Cefadroxil (hydrate)

C3991-500 500 mg
EUR 315.6
Description: Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential [1]. In vitro: The inhibitory activity of this compound was similar to that of cephalexin and cephradine when tested against 602 clinical isolates on Mueller-Hinton medium.

Ivacaftor hydrate

A3511-10 10 mg
EUR 320.4
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis.

Ivacaftor hydrate

A3511-100 100 mg
EUR 1470
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis.

Ivacaftor hydrate

A3511-5 5 mg
EUR 211.2
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis.

Ivacaftor hydrate

A3511-50 50 mg
EUR 1036.8
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis.

CHAPS Hydrate

20-abx082319
  • EUR 226.80
  • EUR 8328.00
  • EUR 360.00
  • 1 g
  • 1 kg
  • 5 g

Entecavir Hydrate

A1767-100 100 mg
EUR 1284
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV.

Entecavir Hydrate

A1767-25 25 mg
EUR 448.8
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV.

Entecavir Hydrate

A1767-5 5 mg
EUR 170.4
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV.

Entecavir Hydrate

A1767-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV.

Doripenem Hydrate

A2036-10 10 mg
EUR 122.4
Description: Doripenem hydrate is a parenteral, potent, and well-balanced antibiotic against a wide range of both Gram+ and Gram- bacteria including Pseudomonas aeruginosa [1].

Doripenem Hydrate

A2036-100 100 mg
EUR 393.6
Description: Doripenem hydrate is a parenteral, potent, and well-balanced antibiotic against a wide range of both Gram+ and Gram- bacteria including Pseudomonas aeruginosa [1].

Doripenem Hydrate

A2036-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Doripenem hydrate is a parenteral, potent, and well-balanced antibiotic against a wide range of both Gram+ and Gram- bacteria including Pseudomonas aeruginosa [1].

Doripenem Hydrate

A2036-50 50 mg
EUR 268.8
Description: Doripenem hydrate is a parenteral, potent, and well-balanced antibiotic against a wide range of both Gram+ and Gram- bacteria including Pseudomonas aeruginosa [1].

Calcipotriol hydrate

20-abx185970
  • EUR 1045.20
  • EUR 477.60
  • 25 mg
  • 5 mg

Methylstat (hydrate)

B2836-1
EUR 170.4

Methylstat (hydrate)

B2836-5
EUR 444

Q-VD-OPh hydrate